|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
25 March 2013 |
|
Main ID: |
NCT01433419 |
|
Date of registration:
|
12/09/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Open-label Study of TAK-875
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
January 2012 |
|
Target sample size:
|
333 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01433419 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention Model: Parallel Assignment
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. The participant is an outpatient.
2. The participant signs and dates a written, informed consent form and any required
privacy authorization prior to the initiation of any study procedures.
Exclusion Criteria:
1. The participant has any serious cardiac disease, serious cerebrovascular disorder, or
any serious pancreatic or hematological disease.
2. The participant is considered ineligible for the study for any other reason by the
investigator or sub-investigator.
Age minimum:
20 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Diabetes Mellitus
|
|
Intervention(s)
|
|
Drug: TAK-875
|
|
Primary Outcome(s)
|
|
Adverse events
[Time Frame: Yes]
|
|
Secondary ID(s)
|
|
JapicCTI-111605
|
|
TAK-875/OCT-003
|
|
U1111-1124-1619
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|